Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-037622
Filing Date
2024-02-15
Accepted
2024-02-15 16:49:55
Documents
4
Period of Report
2024-04-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A d793850dpre14a.htm PRE 14A 96238
2 GRAPHIC g793850dsp015.jpg GRAPHIC 113235
3 GRAPHIC g793850dsp016.jpg GRAPHIC 142111
4 GRAPHIC g793850g00a02.jpg GRAPHIC 36409
  Complete submission text file 0001193125-24-037622.txt   486328
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36571 | Film No.: 24644538
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)